Talis Biomedical Corporation NASDAQ:TLIS Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost and rapid molecular testing for infectious diseases at the point-of-care, beginning with COVID-19. The company is developing Talis One, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform. Talis is headquartered in Menlo Park, California.

Location: | Website: https://talis.bio | Industry: Analytical Laboratory Instrument Manufacturing | Sector: Manufacturing